FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Jubilant Cadista Pharmaceuticals Valsartan Tablets Recall

Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd

Jubilant Cadista Pharmaceuticals, Inc. · Salisbury, MD

Risk level
Class III
Reported by FDA
Jun 13, 2018
Recall ID
D-0876-2018
Check your lot numberHow we source this data

Summary

Jubilant Cadista Pharmaceuticals recalled Valsartan Tablets starting May 25, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0876-2018 on Jun 13, 2018. Reason: Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone). Status: Terminated.

Why it was recalled

Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).

Product description

Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-363-90

Lot numbers, UPCs & expiration codes

Lot #: VR417065A, VR417066A, Exp 10/2019

Where it was sold

IN, MI, MS, NC, NJ, NY and OH

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0876-2018
Classification
Class III
Status
Terminated
Recall initiated
May 25, 2018
FDA report date
Jun 13, 2018
Quantity
2,328 bottles (Lot VR417065A) and 2,352 bottles (Lot VR417066A)
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0876-2018, exactly as published.

Show all FDA fields
City
Salisbury
State
MD
Status
Terminated
Country
United States
Event ID
80133
Address
207 Kiley Dr
Code information
Lot #: VR417065A, VR417066A, Exp 10/2019
Postal code
21801-2249
Report date
Jun 13, 2018
Product type
Drugs
Recall number
D-0876-2018
Classification
Class III
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
Product quantity
2,328 bottles (Lot VR417065A) and 2,352 bottles (Lot VR417066A)
Termination date
Jan 8, 2020
Reason for recall
Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-363-90
Distribution pattern
IN, MI, MS, NC, NJ, NY and OH
Recall initiation date
May 25, 2018
Initial firm notification
Letter
Center classification date
Jun 15, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0876-2018, published Jun 13, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls